Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding? – Authors’ reply. // The Lancet Haematology. – URL: https://www.sciencedirect.com/science/article/pii/S2352302626002553?dgcid=rss_sd_all
Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding? – Authors’ reply. The Lancet Haematology. https://www.sciencedirect.com/science/article/pii/S2352302626002553?dgcid=rss_sd_all
“Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding? – Authors’ reply.” The Lancet Haematology.
@article{article68467,
title = {Improved survival after allo-HCT in Hodgkin lymphoma: true progress or time-dependent confounding? – Authors’ reply},
journal = {The Lancet Haematology},
url = {https://www.sciencedirect.com/science/article/pii/S2352302626002553?dgcid=rss_sd_all}
}